Iron Status in Newly Diagnosed β-Thalassemia Major: High Rate of Iron Status due to Erythropoiesis Drive

Background. Iron overload in severe β-thalassemia is a serious complication that occurs during the course of the disease. Information about the iron status during initial illness with β-thalassemia major seemed to be limited. This study is aimed at analyzing iron status, serum hepcidin, and growth d...

Full description

Bibliographic Details
Main Authors: Susi Susanah, Lulu Eva Rakhmilla, Mohammad Ghozali, Jessica Oktavianus Trisaputra, Octawyana Moestopo, Yunia Sribudiani, Ponpon S. Idjradinata, Ani Melani Maskoen
Format: Article
Language:English
Published: Hindawi Limited 2021-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2021/5560319
id doaj-349c5fc355dc403f944fd6d8a5f37b37
record_format Article
spelling doaj-349c5fc355dc403f944fd6d8a5f37b372021-04-26T00:03:41ZengHindawi LimitedBioMed Research International2314-61412021-01-01202110.1155/2021/5560319Iron Status in Newly Diagnosed β-Thalassemia Major: High Rate of Iron Status due to Erythropoiesis DriveSusi Susanah0Lulu Eva Rakhmilla1Mohammad Ghozali2Jessica Oktavianus Trisaputra3Octawyana Moestopo4Yunia Sribudiani5Ponpon S. Idjradinata6Ani Melani Maskoen7Department of Child HealthDepartment of Public HealthDepartment of Biochemistry and Molecular BiologyFaculty of MedicineFaculty of MedicineDepartment of Biochemistry and Molecular BiologyDepartment of Child HealthDepartment of Biochemistry and Molecular BiologyBackground. Iron overload in severe β-thalassemia is a serious complication that occurs during the course of the disease. Information about the iron status during initial illness with β-thalassemia major seemed to be limited. This study is aimed at analyzing iron status, serum hepcidin, and growth differentiation factor 15 (GDF15) levels in newly diagnosed β-thalassemia major. Methods. A case-control study was performed at Dr. Hasan Sadikin General Hospital, which included 41 children with newly diagnosed β-thalassemia major. Age- and sex-matched controls were enrolled. The subjects had no blood transfusion, had normal liver function, and had no sign of inflammation. The groups were compared in terms of the levels of hemoglobin (Hb), serum ferritin (SF), transferrin saturation (TS), serum hepcidin, and GDF15 as iron homeostasis parameters. Results. Of the 41 newly diagnosed β-thalassemia major patients, those who were less than 24 months old had significantly lower median Hb levels than controls (5.0 vs. 11.7 g/dL, P<0.001). The median SF and TS levels were significantly higher than those in controls (315.0 vs. 29.0 ng/mL, P<0.001; 70.6 vs. 16.5%, P<0.001), and median hepcidin was at the normal limit, but the value was higher in patients (251.0 vs. 123.1 ng/mL, P<0.001). The median GDF15 level was significantly higher in patients (2,095.3 vs. 342.4 pg/mL, P<0.001). There was a positive correlation between SF-TS, SF-hepcidin, TS-hepcidin, SF-GDF15, TS-GDF15, and hepcidin-GDF15 (P<0.001). Conclusion. In newly diagnosed β-thalassemia major, an increase in iron status occurred. This may be caused by increased iron absorption due to massive erythropoietic activity, characterized by an increase in GDF15 levels, which does not cause hepcidin suppression. The iron homeostasis response seems to be physiologically indicated by a tendency to increase hepcidin levels.http://dx.doi.org/10.1155/2021/5560319
collection DOAJ
language English
format Article
sources DOAJ
author Susi Susanah
Lulu Eva Rakhmilla
Mohammad Ghozali
Jessica Oktavianus Trisaputra
Octawyana Moestopo
Yunia Sribudiani
Ponpon S. Idjradinata
Ani Melani Maskoen
spellingShingle Susi Susanah
Lulu Eva Rakhmilla
Mohammad Ghozali
Jessica Oktavianus Trisaputra
Octawyana Moestopo
Yunia Sribudiani
Ponpon S. Idjradinata
Ani Melani Maskoen
Iron Status in Newly Diagnosed β-Thalassemia Major: High Rate of Iron Status due to Erythropoiesis Drive
BioMed Research International
author_facet Susi Susanah
Lulu Eva Rakhmilla
Mohammad Ghozali
Jessica Oktavianus Trisaputra
Octawyana Moestopo
Yunia Sribudiani
Ponpon S. Idjradinata
Ani Melani Maskoen
author_sort Susi Susanah
title Iron Status in Newly Diagnosed β-Thalassemia Major: High Rate of Iron Status due to Erythropoiesis Drive
title_short Iron Status in Newly Diagnosed β-Thalassemia Major: High Rate of Iron Status due to Erythropoiesis Drive
title_full Iron Status in Newly Diagnosed β-Thalassemia Major: High Rate of Iron Status due to Erythropoiesis Drive
title_fullStr Iron Status in Newly Diagnosed β-Thalassemia Major: High Rate of Iron Status due to Erythropoiesis Drive
title_full_unstemmed Iron Status in Newly Diagnosed β-Thalassemia Major: High Rate of Iron Status due to Erythropoiesis Drive
title_sort iron status in newly diagnosed β-thalassemia major: high rate of iron status due to erythropoiesis drive
publisher Hindawi Limited
series BioMed Research International
issn 2314-6141
publishDate 2021-01-01
description Background. Iron overload in severe β-thalassemia is a serious complication that occurs during the course of the disease. Information about the iron status during initial illness with β-thalassemia major seemed to be limited. This study is aimed at analyzing iron status, serum hepcidin, and growth differentiation factor 15 (GDF15) levels in newly diagnosed β-thalassemia major. Methods. A case-control study was performed at Dr. Hasan Sadikin General Hospital, which included 41 children with newly diagnosed β-thalassemia major. Age- and sex-matched controls were enrolled. The subjects had no blood transfusion, had normal liver function, and had no sign of inflammation. The groups were compared in terms of the levels of hemoglobin (Hb), serum ferritin (SF), transferrin saturation (TS), serum hepcidin, and GDF15 as iron homeostasis parameters. Results. Of the 41 newly diagnosed β-thalassemia major patients, those who were less than 24 months old had significantly lower median Hb levels than controls (5.0 vs. 11.7 g/dL, P<0.001). The median SF and TS levels were significantly higher than those in controls (315.0 vs. 29.0 ng/mL, P<0.001; 70.6 vs. 16.5%, P<0.001), and median hepcidin was at the normal limit, but the value was higher in patients (251.0 vs. 123.1 ng/mL, P<0.001). The median GDF15 level was significantly higher in patients (2,095.3 vs. 342.4 pg/mL, P<0.001). There was a positive correlation between SF-TS, SF-hepcidin, TS-hepcidin, SF-GDF15, TS-GDF15, and hepcidin-GDF15 (P<0.001). Conclusion. In newly diagnosed β-thalassemia major, an increase in iron status occurred. This may be caused by increased iron absorption due to massive erythropoietic activity, characterized by an increase in GDF15 levels, which does not cause hepcidin suppression. The iron homeostasis response seems to be physiologically indicated by a tendency to increase hepcidin levels.
url http://dx.doi.org/10.1155/2021/5560319
work_keys_str_mv AT susisusanah ironstatusinnewlydiagnosedbthalassemiamajorhighrateofironstatusduetoerythropoiesisdrive
AT luluevarakhmilla ironstatusinnewlydiagnosedbthalassemiamajorhighrateofironstatusduetoerythropoiesisdrive
AT mohammadghozali ironstatusinnewlydiagnosedbthalassemiamajorhighrateofironstatusduetoerythropoiesisdrive
AT jessicaoktavianustrisaputra ironstatusinnewlydiagnosedbthalassemiamajorhighrateofironstatusduetoerythropoiesisdrive
AT octawyanamoestopo ironstatusinnewlydiagnosedbthalassemiamajorhighrateofironstatusduetoerythropoiesisdrive
AT yuniasribudiani ironstatusinnewlydiagnosedbthalassemiamajorhighrateofironstatusduetoerythropoiesisdrive
AT ponponsidjradinata ironstatusinnewlydiagnosedbthalassemiamajorhighrateofironstatusduetoerythropoiesisdrive
AT animelanimaskoen ironstatusinnewlydiagnosedbthalassemiamajorhighrateofironstatusduetoerythropoiesisdrive
_version_ 1714657646666055680